한국어
Quantus

Gossamer Bio

GOSS · Nasdaq
$0.1753-0.17%
2026-09-04 close

Gossamer Bio last closed at $0.1753 (-0.17%) on 2026-09-04. Listed on Nasdaq; price, financials and dividends update daily after market close.

Loading chart…
Close
No active signal.

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
277 picks
Next-day win rate
44.2%
Avg next-day
-0.28%
vs market
-0.51%p

Every new-high-plus-volume pick we actually published (US market) — not this stock alone.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

A-
Overall: 건강관리 199/745 · top 27%
Factor composite · relative position in sector

PER — · PBR 1.38 — own-history percentile 9/100 · 99/100

Open self-history band
PER9/100
PBR99/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2024
Distress zoneFinancial-metric reference signal
Altman Z'' zoneZ'' -8.77
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
-8.77
Beneish M-Score
—

Statistical flag unavailable

Sloan accrual
-16.83%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

3/9Weak

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score3/9

Profitability

  • Positive ROANot passed
  • Positive OCFNot passed
  • Improving ΔROAPass
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioPass
  • No new sharesNot passed

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Industry structure

USAs of 2026-09-05

건강관리

This stock is in 건강관리: revenue rank 266 of 543, share 0%.

266 / 5430%revenue share

Who dominates this industry?

  1. 1CVS Health14.1%
  2. 2McKesson13.6%
  3. 3Cigna9.4%
  4. 4Cardinal Health8.4%
  5. 5Centene6.2%
  6. 6Gossamer Bio0%

Concentration

DistributedCR3 37.1%
HHI 642543 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

Winner-take-all deepeningConsistent

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p
159.97
Direction
축소
Level
넓음
Years
21

Value lens

P90/P10
24.4
Median P/B
3.02
Level
넓음
n
463

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
-52.2%
Interest coverage
-5.2x
Return on equity (ROE)
-191.7%

Operating margin −5pp

Operating loss
Interest coverageBase -5.2x adverse case -5.7x
Return on equity (ROE)Base -191.7% adverse case -261.7%

Revenue −15%

Interest coverage risk
Interest coverageBase -5.2x adverse case -4.4x
Return on equity (ROE)Base -191.7% adverse case -211.7%

Interest rate +2pp

Interest coverage risk
Interest coverageBase -5.2x adverse case -3.5x
Return on equity (ROE)Base -191.7% adverse case -261.6%

Interest coverage limit

Already below the limit by 62.3pp

Interest coverage limit at an operating margin of 10%

Interest expense coverage threshold

Connections

AI-extracted related companies · for reference

🔗 See in the full market map →

Recent filings

Filings for overseas stocks are on the way. For now we cover Korean stocks only.

About Gossamer Bio
What technical signals does Gossamer Bio (GOSS) have?
Gossamer Bio current technical signals: no active technical signal.
Is Gossamer Bio a cup-and-handle pattern?
No. Gossamer Bio has no valid cup-and-handle signal right now.
What are Gossamer Bio's financials and valuation?
Gossamer Bio's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy